Identification of a familial hyperinsulinism-causing mutation in the sulfonylurea receptor 1 that prevents normal

Grit Taschenberger1, Adam Mougey, Shu Shen

  • 1Center for Research on Occupational and Environmental Toxicology, the Department of Medicine, Oregon Health and Science University, Portland, Oregon 97201, USA.

Insights

Persistent hyperinsulinemic hypoglycemia of infancy is linked to K(ATP) channel mutations. The L1544P mutation in SUR1 impairs channel trafficking by disrupting ER retention signals, leading to reduced surface expression.

Area of Science:

  • Molecular biology
  • Cell biology
  • Genetics

Background:

  • Persistent hyperinsulinemic hypoglycemia of infancy (PHI) is a rare genetic disorder.
  • Mutations in pancreatic ATP-sensitive potassium (K(ATP)) channel subunits, sulfonylurea receptor 1 (SUR1) and Kir6.2, are known causes of PHI.
  • Understanding the molecular mechanisms underlying these mutations is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the functional and trafficking consequences of a novel SUR1 mutation, L1544P, identified in a patient with PHI.
  • To elucidate the role of endoplasmic reticulum (ER) retention signals in K(ATP) channel assembly and surface expression.

Main Methods:

  • Co-expression of wild-type and mutant SUR1 with Kir6.2 in COS cells.
  • Functional assessment of K(ATP) channel activity using MgADP response.
  • Quantification of channel surface expression via cell surface biotinylation.
  • Analysis of protein degradation pathways (lysosomal and proteasomal).
  • Site-directed mutagenesis to remove ER retention motifs (RKR).

Main Results:

  • The L1544P SUR1 mutation significantly reduced K(ATP) channel response to MgADP (approx. 10% of wild-type).
  • Surface expression of K(ATP) channels with L1544P SUR1 was markedly decreased (approx. 19% of wild-type).
  • The mutation did not affect the steady-state level of SUR1 protein, and degradation pathways were not implicated.
  • Removal of the RKR ER retention motif in SUR1 or Kir6.2 individually increased mutant channel surface expression.
  • Simultaneous removal of the RKR motif in both subunits restored surface expression to wild-type levels.

Conclusions:

  • The L1544P mutation impairs K(ATP) channel function and surface expression in PHI.
  • The mutation likely interferes with proper K(ATP) channel trafficking by disrupting the shielding of ER retention signals.
  • Targeting ER trafficking mechanisms may offer therapeutic strategies for PHI caused by such mutations.

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Oral Hypoglycemic Agents: Sulfonylureas01:17

Oral Hypoglycemic Agents: Sulfonylureas

Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide (Glucotrol),...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...